Stay updated on TAK-861 in Narcolepsy Type 1 Clinical Trial
Sign up to get notified when there's something new on the TAK-861 in Narcolepsy Type 1 Clinical Trial page.

Latest updates to the TAK-861 in Narcolepsy Type 1 Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s revision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 has been added. Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded the 2026 JAMA Neurology citation for Oveporexton and removed the 2025 ahead-of-print citation for the same article.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded a site revision note (Revision: v3.4.2) and removed an older funding-status notice; no study-specific content, eligibility criteria, or results were changed.SummaryDifference0.3%

- Check81 days agoChange DetectedAdded a site-wide notice about government funding lapse and updated operating status guidance, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to TAK-861 in Narcolepsy Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-861 in Narcolepsy Type 1 Clinical Trial page.